FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.464.1003.196.12.1480

Resources that use this resource

No resources found

Resources that this resource uses

Narrative

No narrative content found in resource

Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.196.12.1480",
  "meta": {
    "versionId": "2",
    "lastUpdated": "2024-01-24T09:23:04.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "NCQA PHEMUR Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-02-04"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2017-05-04"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1480",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.196.12.1480"
    }
  ],
  "version": "20170504",
  "name": "PotentiallyHarmfulNonbenzodiazepineHypnoticsForOlderAdults",
  "title": "Potentially Harmful Nonbenzodiazepine Hypnotics for Older Adults",
  "status": "active",
  "experimental": false,
  "date": "2017-05-04T01:00:13-04:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for potentially harmful Nonbenzodiazepine Hypnotics for older adults as described in the 2023 American Geriatrics Society BEERS criteria.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable nonbenzodiazepine hypnotic medication.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and concepts that represent components or ingredients.)",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1481"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:66d69f2b-0f2f-4538-8490-cb558e340c2f",
    "timestamp": "2025-05-23T22:32:13-04:00",
    "total": 15,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1232194",
        "display": "zolpidem tartrate 1.75 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1232202",
        "display": "zolpidem tartrate 3.5 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "2637353",
        "display": "zolpidem tartrate 7.5 MG Oral Capsule"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "313761",
        "display": "zaleplon 10 MG Oral Capsule"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "313762",
        "display": "zaleplon 5 MG Oral Capsule"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "485440",
        "display": "eszopiclone 1 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "485442",
        "display": "eszopiclone 2 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "485465",
        "display": "eszopiclone 3 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "828692",
        "display": "zolpidem tartrate 5 MG/ACTUAT Oral Spray"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "836641",
        "display": "zolpidem tartrate 10 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "836647",
        "display": "zolpidem tartrate 5 MG Sublingual Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "854873",
        "display": "zolpidem tartrate 10 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "854876",
        "display": "zolpidem tartrate 5 MG Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "854880",
        "display": "zolpidem tartrate 12.5 MG Extended Release Oral Tablet"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "854894",
        "display": "zolpidem tartrate 6.25 MG Extended Release Oral Tablet"
      }
    ]
  }
}